FDA-approved Produicts

FDA, Alnylam

FDA greenlights new drug to treat a serious type of heart disease

Heart disease patients now have another treatment option. The U.S. Food and Drug Administration has approved Alnylam Pharmaceuticals’ treatment for a progr

Wall Street Journal · 17h

Alnylam Stock Jumps After the FDA Approves Its Heart Drug

Alnylam Pharmaceuticals shares rose 10% Friday after the company nabbed FDA approval to sell its drug Amvuttra to a larger population of patients with a genetic heart condition. The FDA

The Business Journals · 1d

Alnylam wins FDA approval for rare heart disease drug

Alnylam Pharmaceuticals Inc. won a major FDA approval on Thursday, one that could propel the Cambridge company toward a major milestone — finally reaching profitability.

MPR13h

FDA Approves Gvoke VialDx to Inhibit GI Motility During Diagnostic Procedures

Gvoke VialDx is a concentrated liquid glucagon product. For diagnostic procedures, it works as a gastrointestinal motility inhibitor. The product is supplied as a single-dose vial containing 1mg of ...

CNET on MSN14d

Natural Medicine vs. FDA Drugs: Which Should You Use for Your Ailment?

FDA-approved drugs are also often patented and subject to various laws regarding exclusivity for a given manufacturer. At the same time, natural medications are often freely available as food and ...

11d

Male enhancement capsules recalled for undeclared ingredients, FDA announces

One Source Nutrition, Inc. is voluntarily recalling all of its Vitality male enhancement capsules nationwide after an FDA ...

JD Supra5h

FDA’s Semaglutide Shortage Resolution: Legal Implications and Risks for Compounding Pharmacies

Last month, the U.S. Food and Drug Administration (the “FDA”) announced in a Declaratory Order the resolution of the shortage of semaglutide ...

Novartis1d

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G)

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...

15don MSN

Key takeaways from Marty Makary’s FDA confirmation hearing

Marty Makary, a career surgeon and President Trump’s nominee to run the Food and Drug Administration (FDA), faced senators in his confirmation hearing on Thursday, aligning himself with the Make ...

Targeted Oncology1d

FDA OKs TLX007-CDx in Prostate Cancer Treatment

TLX007-CDx is a cold kit designed for the preparation of PSMA-targeted PET imaging for prostate cancer. It leverages ...

JD Supra8d

FDA Resolves Semaglutide Shortage: Next Steps for Community Pharmacies, Telehealth Companies, and Other Providers

Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results